Fractyl Health Participation in Major Healthcare Event
Fractyl Health, Inc. (NASDAQ: GUTS), based in Burlington, has announced its active participation in a significant healthcare conference. During the 8th Annual Evercore Healthcare Conference, scheduled for early December, Co-Founder and CEO Harith Rajagopalan, M.D., Ph.D., will engage in a fireside chat. This event highlights the company's commitment to addressing metabolic health challenges.
Details of the 8th Annual Evercore Healthcare Conference
Event Overview
The 8th Annual Evercore Healthcare Conference provides an excellent platform for discussions on advancements in healthcare, particularly in the fields of obesity and type 2 diabetes management. The format includes a fireside chat and opportunities for one-on-one meetings, allowing for in-depth dialogue about the future of metabolic therapies.
Timing of the Session
The chat is scheduled for December 3 at 1:45 PM ET, offering an accessible format for investors and interested parties to learn about Fractyl's innovative approaches to combatting metabolic diseases.
Fractyl Health's Mission and Goals
Fractyl Health is not just participating in events but is also significantly enhancing the landscape of metabolic disease treatment. The company aims to reshape how obesity and type 2 diabetes are approached by moving from mere symptomatic management to therapies that address root causes of these conditions.
Innovative Treatments for Metabolic Diseases
Chronic Conditions and New Approaches
Despite the medical advancements over the last several decades, obesity and type 2 diabetes remain significant health issues globally. Fractyl is dedicated to pioneering treatments that could lead to durable solutions. Their innovative therapies represent a paradigm shift in the management of metabolic disorders.
Intellectual Property and Development
The company boasts a formidable intellectual property portfolio with 33 granted U.S. patents and around 45 pending applications. This strength in IP reflects Fractyl's dedication to research and development, ensuring continuous innovation in their treatment approaches.
Company Contact Information
If you are interested in learning more about Fractyl Health and their initiatives, please reach out to Brian Luque, the Head of Investor Relations and Corporate Development. You can contact him via email at IR@fractyl.com or by phone at 951.206.1200.
Frequently Asked Questions
What is Fractyl Health's focus?
Fractyl Health is committed to developing new treatment approaches for obesity and type 2 diabetes, addressing the root causes of these metabolic diseases.
When is the Evercore Healthcare Conference?
The conference will take place from December 2 to 4, with Fractyl's session on December 3 at 1:45 PM ET.
How can I access the webcast of the session?
A webcast replay of the session will be available on Fractyl's Investors section of their website following the live event.
Where is Fractyl Health located?
Fractyl Health is headquartered in Burlington, Massachusetts.
Who can I contact for investor inquiries?
You can reach out to Brian Luque at IR@fractyl.com for any investor-related questions or information.